FindTrial
Sign In

Application of novel pathogen detection technology in the diagnosis and treatment of community-acquired pneumonia after initial treatment failure

Application of novel pathogen detection technology in the diagnosis and treatment of community-acquired pneumonia after initial treatment failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063453
Enrollment
Unknown
Registered
2022-09-07
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community-acquired pneumonia

Interventions

Gold Standard:Medical history, clinical findings and laboratory results
Index test:mNGS and tNGS

Sponsors

Affiliated Jinling Hospital, Medical School of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The patient aged over 18 years; 2. Patients meet the diagnostic criteria for community-acquired pneumonia after initial treatment failure; 3. Agree to join in; 4. The specimen meets the requirements.

Exclusion criteria

Exclusion criteria: 1. Hospitalization within the last past 3 months; 2. With chronic structural lung disease; 3. Severe immune deficiency; 4. Incomplete medical history or loss to follow-up.

Design outcomes

Primary

MeasureTime frame
pathogen;—

Countries

China

Contacts

Public ContactXin Su

Affiliated Jinling Hospital, Medical School of Nanjing University

suxinjs@163.com+86 13770619730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026